€1.17 0.0 0.9%
Last Trade - 12:14pm
| Market Cap | ÂŁ108.5m |
| Enterprise Value | ÂŁ99.2m |
| Revenue | ÂŁ7.80m |
| Position in Universe | 497th / 847 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.7 | 17.6 | 30.0 | 40.5 | 28.4 | 11.8 | 21.0 | 27.7 | +0.2% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | January 15, 2003 |
| Public Since | June 28, 2006 |
| No. of Shareholders: | n/a |
| No. of Employees: | 177 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Euronext - Brussels |
| Shares in Issue | 108,829,737 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | CAP Business Center Rue d'Abhooz 31, HERSTAL, 4040, Belgium |
| Web | https://mdxhealth.com/ |
| Phone | +32 4 2577021 |
| Contact | () |
| Auditors | BDO Reviseurs d Entreprises |
As of 12:14pm, shares in MDxHealth SA are trading at €1.17, giving the company a market capitalisation of £108.5m. This share price information is delayed by 15 minutes.
Shares in MDxHealth SA are currently trading at €1.17 and the price has moved by 41.05% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the MDxHealth SA price has moved by 27.35% over the past year.
Of the analysts with advisory recommendations for MDxHealth SA, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for MDxHealth SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
MDxHealth SA is scheduled to issue upcoming financial results on the following dates:
MDxHealth SA does not currently pay a dividend.
MDxHealth SA does not currently pay a dividend.
MDxHealth SA does not currently pay a dividend.
To buy shares in MDxHealth SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in MDxHealth SA are currently trading at €1.17, giving the company a market capitalisation of £108.5m.
Here are the trading details for MDxHealth SA:
Based on an overall assessment of its quality, value and momentum, MDxHealth SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in MDxHealth SA are currently priced at €1.17. At that level they are trading at 2.9% discount to the analyst consensus target price of 0.00.
Analysts covering MDxHealth SA currently have a consensus Earnings Per Share (EPS) forecast of -0.379 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MDxHealth SA. Over the past six months, the relative strength of its shares against the market has been 46.59%. At the current price of €1.17, shares in MDxHealth SA are trading at 37% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for MDxHealth SA.
MDxHealth SA's management team is headed by:
Here are the top five shareholders of MDxHealth SA based on the size of their shareholding:
